Cimetidine Disposition in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
- 6 May 1983
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 23 (5-6) , 252-256
- https://doi.org/10.1002/j.1552-4604.1983.tb02732.x
Abstract
Cimetidine disposition was determined in six patients undergoing continuous ambulatory peritoneal dialysis to ascertain the need for modification of conventional dosing regimens. Blood, dialysis fluid, and urine were collected for 48 hours after administration of a single intravenous dose of cimetidine. The following values were obtained: elimination half‐life, 4.3 hours; systemic or total body clearance, 191 ± 55 ml/min; and dialysis clearance, 4.2 ± 3.1 ml/min. Approximately 2% of a cimetidine dose is removed by dialysis, indicating that there is no need to adjust the conventional renal failure dosing regimen in patients undergoing continuous ambulatory peritoneal dialysis.This publication has 15 references indexed in Scilit:
- Drugs Five Years Later: Cimetidine: II. Adverse Reactions and Patterns of UseAnnals of Internal Medicine, 1982
- Steady-state Kinetics and Dosage Requirements of Cimetidine in Renal FailureClinical Pharmacokinetics, 1981
- Pharmacokinetics of Cimetidine after Single Doses and during Continuous TreatmentClinical Pharmacokinetics, 1981
- Removal of Cimetidine by Peritoneal Dialysis, Hemodialysis, and Charcoal HemoperfusionTherapeutic Drug Monitoring, 1980
- Therapeutic effect of cimetidine in patients undergoing haemodialysis.BMJ, 1979
- Bioavailability of cimetidine in manGastroenterology, 1978
- High-Pressure Liquid Chromatographic Analysis of Cimetidine, a Histamine H2-Heceptor Antagonist, in Blood and UrineJournal of Pharmaceutical Sciences, 1977
- Further Studies of Gastric Hypersecretion in Chronic Renal FailureBMJ, 1974
- PEPTIC ULCERATION IN CHRONIC RENAL FAILUREThe Lancet, 1973
- Gastric Acid Secretion in Chronic Renal FailureBMJ, 1972